Gerontechnology, Viagra, and other PDE-5 inhibitors
J. Hillman
Full text PDF 
( Download count: 8661)
AbstractStudies worldwide suggest that the majority of men maintain moderate to high levels of sexual interest throughout the lifespan, but often report some degree of sexual dysfunction. This review is designed to provide essential information regarding erectile dysfunction (ED) and its treatment with Viagra (sildenafil) and other phosphodiesterase-5 (PDE-5) inhibitors (i.e., Levitra and Cialis). The prevalence and etiology of ED, in comparison to the normal changes associated with aging, are presented. Misconceptions about Viagra and other PDE-5 inhibitors, as well as these drugs’ mechanism of action, clinical efficacy, side-effects, and contraindications are discussed, and the impact of these male enhancement drugs upon sexual partners, their possible use among women, and the influence of extensive product marketing campaigns are addressed. The potential for gerontechnology to assist men with treatment of ED via health education, e-health information, and concurrent sex therapy is highlighted. The overarching goal is to assist men and their partners in making informed decisions about appropriate performance enhancement drug use, as well avoiding its potential misuse.Keywords: Gerontechnology; sexual behavior; erectile dysfunction; older adults
J. Hillman (2009). Gerontechnology, Viagra, and other PDE-5 inhibitors. Gerontechnology, 8(4), 197-208
https://doi.org/10.4017/gt.2009.08.04.002.00